132 related articles for article (PubMed ID: 19714587)
1. Polymyalgia rheumatica prevalence in a population-based sample.
Bernatsky S; Joseph L; Pineau CA; Belisle P; Lix L; Banerjee D; Clarke AE
Arthritis Rheum; 2009 Sep; 61(9):1264-7. PubMed ID: 19714587
[TBL] [Abstract][Full Text] [Related]
2. Scleroderma prevalence: demographic variations in a population-based sample.
Bernatsky S; Joseph L; Pineau CA; Belisle P; Hudson M; Clarke AE
Arthritis Rheum; 2009 Mar; 61(3):400-4. PubMed ID: 19248123
[TBL] [Abstract][Full Text] [Related]
3. Estimating the prevalence of polymyositis and dermatomyositis from administrative data: age, sex and regional differences.
Bernatsky S; Joseph L; Pineau CA; Bélisle P; Boivin JF; Banerjee D; Clarke AE
Ann Rheum Dis; 2009 Jul; 68(7):1192-6. PubMed ID: 18713785
[TBL] [Abstract][Full Text] [Related]
4. A population-based assessment of systemic lupus erythematosus incidence and prevalence--results and implications of using administrative data for epidemiological studies.
Bernatsky S; Joseph L; Pineau CA; Tamblyn R; Feldman DE; Clarke AE
Rheumatology (Oxford); 2007 Dec; 46(12):1814-8. PubMed ID: 18032538
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of systemic lupus erythematosus and systemic sclerosis in the First Nations population of Alberta, Canada.
Barnabe C; Joseph L; Belisle P; Labrecque J; Edworthy S; Barr SG; Fritzler M; Svenson LW; Hemmelgarn B; Bernatsky S
Arthritis Care Res (Hoboken); 2012 Jan; 64(1):138-43. PubMed ID: 21972194
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of autoimmune inflammatory myopathy in the first nations population of Alberta, Canada.
Barnabe C; Joseph L; Bélisle P; Labrecque J; Barr SG; Fritzler MJ; Svenson LW; Peschken CA; Hemmelgarn B; Bernatsky S
Arthritis Care Res (Hoboken); 2012 Nov; 64(11):1715-9. PubMed ID: 22623451
[TBL] [Abstract][Full Text] [Related]
7. Stroke surveillance in Manitoba, Canada: estimates from administrative databases.
Moore DF; Lix LM; Yogendran MS; Martens P; Tamayo A
Chronic Dis Can; 2008; 29(1):22-30. PubMed ID: 19036220
[TBL] [Abstract][Full Text] [Related]
8. Bayesian modelling of imperfect ascertainment methods in cancer studies.
Bernatsky S; Joseph L; Bélisle P; Boivin JF; Rajan R; Moore A; Clarke A
Stat Med; 2005 Aug; 24(15):2365-79. PubMed ID: 15977290
[TBL] [Abstract][Full Text] [Related]
9. Systemic autoimmune rheumatic disease prevalence in Canada: updated analyses across 7 provinces.
Broten L; Aviña-Zubieta JA; Lacaille D; Joseph L; Hanly JG; Lix L; O'Donnell S; Barnabe C; Fortin PR; Hudson M; Jean S; Peschken C; Edworthy SM; Svenson L; Pineau CA; Clarke AE; Smith M; Bélisle P; Badley EM; Bergeron L; Bernatsky S
J Rheumatol; 2014 Apr; 41(4):673-9. PubMed ID: 24584928
[TBL] [Abstract][Full Text] [Related]
10. Small-vessel vasculitis surrounding an uninflamed temporal artery: a new diagnostic criterion for polymyalgia rheumatica?
Chatelain D; Duhaut P; Loire R; Bosshard S; Pellet H; Piette JC; Sevestre H; Ducroix JP
Arthritis Rheum; 2008 Aug; 58(8):2565-73. PubMed ID: 18668584
[TBL] [Abstract][Full Text] [Related]
11. Use of physician services in a population-based cohort of patients with polymyalgia rheumatica over the course of their disease.
Kremers HM; Reinalda MS; Crowson CS; Zinsmeister AR; Hunder GG; Gabriel SE
Arthritis Rheum; 2005 Jun; 53(3):395-403. PubMed ID: 15934100
[TBL] [Abstract][Full Text] [Related]
12. No increased frequency of malignant neoplasms in polymyalgia rheumatica and temporal arteritis. A prospective longitudinal study of 398 cases and matched population controls.
Myklebust G; Wilsgaard T; Jacobsen BK; Gran JT
J Rheumatol; 2002 Oct; 29(10):2143-7. PubMed ID: 12375324
[TBL] [Abstract][Full Text] [Related]
13. Do variations in disease prevalence limit the usefulness of population-based hospitalization rates for studying variations in hospital admissions?
Shwartz M; Peköz EA; Ash AS; Posner MA; Restuccia JD; Iezzoni LI
Med Care; 2005 Jan; 43(1):4-11. PubMed ID: 15626928
[TBL] [Abstract][Full Text] [Related]
14. Validity of the polymyalgia rheumatica activity score in primary care practice.
Binard A; Lefebvre B; De Bandt M; Berthelot JM; Saraux A;
Ann Rheum Dis; 2009 Apr; 68(4):541-5. PubMed ID: 18477738
[TBL] [Abstract][Full Text] [Related]
15. Rheumatoid arthritis prevalence in Quebec.
Bernatsky S; Dekis A; Hudson M; Pineau CA; Boire G; Fortin PR; Bessette L; Jean S; Chetaille AL; Belisle P; Bergeron L; Feldman DE; Joseph L
BMC Res Notes; 2014 Dec; 7():937. PubMed ID: 25527187
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of the disease activity scores for polymyalgia rheumatica for predicting glucocorticoid dose changes: a study of 243 scenarios.
Binard A; De Bandt M; Berthelot JM; Saraux A;
Arthritis Rheum; 2007 Apr; 57(3):481-6. PubMed ID: 17394219
[TBL] [Abstract][Full Text] [Related]
17. Performance of the polymyalgia rheumatica activity score for diagnosing disease flares.
Binard A; de Bandt M; Berthelot JM; Saraux A;
Arthritis Rheum; 2008 Feb; 59(2):263-9. PubMed ID: 18240260
[TBL] [Abstract][Full Text] [Related]
18. Robustness of prevalence estimates derived from misclassified data from administrative databases.
Ladouceur M; Rahme E; Pineau CA; Joseph L
Biometrics; 2007 Mar; 63(1):272-9. PubMed ID: 17447953
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of polymyalgia rheumatica in Colombia: data from the national health registry 2012-2016.
Fernández-Ávila DG; Bernal-Macías S; Rincón-Riaño DN; Gutiérrez JM; Rosselli D
Rheumatol Int; 2019 Sep; 39(9):1631-1635. PubMed ID: 31327052
[TBL] [Abstract][Full Text] [Related]
20. Twenty-year trends in the incidence and prevalence of diagnosed anogenital warts in Canada.
Kliewer EV; Demers AA; Elliott L; Lotocki R; Butler JR; Brisson M
Sex Transm Dis; 2009 Jun; 36(6):380-6. PubMed ID: 19556932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
